Loading financials from SEC filings…
REITs · Real Estate · Fiscal year ends Dec 31
Healthcare Realty Trust reported revenue of $28M in the fiscal year ended Dec 2025, up 47.3% from the year before. Net income was −$246M. Operating cash flow of $457M less capital expenditure of $13M left free cash flow of $444M. Net debt was $3.9B.
Ranks among the 75 reits companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 10.3 | 13.7 | 17.5 | 19.2 | 28.2 |
| Operating incomederived: revenue − total costs | −696 | – | – | – | – |
| Interest expense | 53.1 | 147 | 259 | 242 | 209 |
| Net income | 66.7 | 40.9 | −278 | −654 | −246 |
| Diluted EPS | 0.45 | 0.15 | −0.74 | −1.81 | −0.71 |
| Diluted shares | 143 | 254 | 379 | 366 | 350 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 13.2 | 61.0 | 25.7 | 68.9 | 26.2 |
| Goodwill | 3.5 | 223 | 251 | 0.0 | – |
| Total assets | 4,259 | 13,850 | 12,637 | 10,651 | 9,211 |
| Deferred revenue | 45.1 | 87.3 | – | – | – |
| Long-term debt | 1,801 | 5,352 | 4,995 | 4,663 | 3,911 |
| Total liabilities | 2,074 | 6,168 | 5,714 | 5,345 | 4,534 |
| Shareholders' equity | 2,185 | 7,571 | 6,823 | 5,235 | 4,617 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 233 | 273 | 500 | 502 | 457 |
| Capital expenditure | 97.2 | 37.9 | 41.1 | 70.3 | 12.6 |
| Free cash flow | 135 | 235 | 459 | 431 | 444 |
| Depreciation & amortisation | 203 | 453 | 731 | 675 | 564 |
| Stock-based compensation | 10.7 | 20.3 | 14.3 | 31.8 | 22.4 |
| Share buybacks | 3.8 | 3.2 | 2.3 | 8.9 | 4.0 |
| Dividends paid | 175 | 284 | 472 | 458 | 387 |
| Dividend per share | 1.21 | 1.24 | 1.24 | 1.24 | 1.10 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 33.2% | 27.3% | 9.8% | 47.3% |
| EPS growth (YoY) | – | −66.7% | −593.3% | – | – |
| Operating margin | −6765.2% | – | – | – | – |
| Net margin | 647.7% | 298.4% | −1594.5% | −3416.4% | −872.1% |
| Return on equityBlank when equity is negative | 3.1% | 0.5% | −4.1% | −12.5% | −5.3% |
| Free cash flow margin | 1316.4% | 1713.7% | 2628.9% | 2251.3% | 1575.3% |
| Cash conversion (CFO ÷ net income) | 3.49x | 6.67x | −1.80x | −0.77x | −1.86x |
| Interest cover | −13.1x | – | – | – | – |
| Debt ÷ equity | 0.82x | 0.71x | 0.73x | 0.89x | 0.85x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 1,788 | 5,291 | 4,969 | 4,594 | 3,885 |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.